PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review

Recently, the development of immunotherapy through the immune checkpoint blockade led to long-lasting responses in several types of cancers that are refractory to conventional treatments, such as melanoma or non-small cell lung cancer. Immunotherapy has also demonstrated significant improvements in...

Descripción completa

Detalles Bibliográficos
Autores principales: Planes-Laine, Gabrielle, Rochigneux, Philippe, Bertucci, François, Chrétien, Anne-Sophie, Viens, Patrice, Sabatier, Renaud, Gonçalves, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679223/
https://www.ncbi.nlm.nih.gov/pubmed/31336685
http://dx.doi.org/10.3390/cancers11071033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679223/
https://www.ncbi.nlm.nih.gov/pubmed/31336685
http://dx.doi.org/10.3390/cancers11071033

Ejemplares similares